Clinical trial
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
NCT05468203 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
- Lead sponsor
- The George Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 29, 2023
- Completion date
- December 23, 2025
- Enrollment
- 51 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.